These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34738731)

  • 1. Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.
    Tsai HI; Wu Y; Liu X; Xu Z; Liu L; Wang C; Zhang H; Huang Y; Wang L; Zhang W; Su D; Khan FU; Zhu X; Yang R; Pang Y; Eriksson JE; Zhu H; Wang D; Jia B; Cheng F; Chen H
    Adv Sci (Weinh); 2022 Jan; 9(3):e2102634. PubMed ID: 34738731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1.
    Li M; Soder R; Abhyankar S; Abdelhakim H; Braun MW; Trinidad CV; Pathak HB; Pessetto Z; Deighan C; Ganguly S; Dawn B; McGuirk J; Dunavin N; Godwin AK
    J Extracell Vesicles; 2021 Feb; 10(4):e12067. PubMed ID: 33598108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small extracellular vesicles derived from PD-L1-modified mesenchymal stem cell promote Tregs differentiation and prolong allograft survival.
    Ou Q; Dou X; Tang J; Wu P; Pan D
    Cell Tissue Res; 2022 Sep; 389(3):465-481. PubMed ID: 35688948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell-Derived Extracellular Vesicles with High PD-L1 Expression for Autoimmune Diseases Treatment.
    Xu F; Fei Z; Dai H; Xu J; Fan Q; Shen S; Zhang Y; Ma Q; Chu J; Peng F; Zhou F; Liu Z; Wang C
    Adv Mater; 2022 Jan; 34(1):e2106265. PubMed ID: 34613627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy.
    Wan WJ; Huang G; Wang Y; Tang Y; Li H; Jia CH; Liu Y; You BG; Zhang XN
    Acta Biomater; 2021 Dec; 136():473-484. PubMed ID: 34571271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effect of small extracellular vesicle PD-L1 is restricted by co-expression of CD80.
    Liu JY; Yu ZL; Fu QY; Zhang LZ; Li JB; Wu M; Liu B; Chen G
    Br J Cancer; 2023 Oct; 129(6):925-934. PubMed ID: 37532831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response.
    Zhang Y; Zhang K; Wen H; Ge D; Gu J; Zhang C
    Clin Exp Immunol; 2024 Mar; 216(1):68-79. PubMed ID: 38146642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Programmed Death Ligand-1/Cytotoxic T-Lymphocyte-Associated Antigen-4 Dual-Targeting Nanovesicles for Immunosuppressive Therapy in Transplantation.
    Xu Z; Tsai HI; Xiao Y; Wu Y; Su D; Yang M; Zha H; Yan F; Liu X; Cheng F; Chen H
    ACS Nano; 2020 Jul; 14(7):7959-7969. PubMed ID: 32515579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-Assisted Traceless Isolation of PD-L1-Positive Small Extracellular Vesicles for Dissecting Their Subpopulation Signature and Function.
    Xu R; Yu ZL; Liu XC; Xie QH; Wu M; Chen G
    Anal Chem; 2023 Jan; 95(2):1016-1026. PubMed ID: 36534080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
    Chen Q; Zhou R; Zhang Y; Zhu S; Xiao C; Gong J; Li K; Tang H; Sun C; Zhang J
    Transpl Immunol; 2018 Dec; 51():21-29. PubMed ID: 30092337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8
    Guo M; Yuan F; Qi F; Sun J; Rao Q; Zhao Z; Huang P; Fang T; Yang B; Xia J
    J Transl Med; 2020 Aug; 18(1):306. PubMed ID: 32762721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor BMSC-derived small extracellular vesicles relieve acute rejection post-renal allograft through transmitting Loc108349490 to dendritic cells.
    Wang ZG; Xu HE; Cheng FM; Zhang J; Feng YH; Liu DH; Shang WJ; Feng GW
    Aging Cell; 2021 Oct; 20(10):e13461. PubMed ID: 34499402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery.
    Jung D; Shin S; Kang SM; Jung I; Ryu S; Noh S; Choi SJ; Jeong J; Lee BY; Kim KS; Kim CS; Yoon JH; Lee CH; Bucher F; Kim YN; Im SH; Song BJ; Yea K; Baek MC
    J Extracell Vesicles; 2022 Dec; 11(12):e12287. PubMed ID: 36447429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow mesenchymal stromal cells protect allograft lung transplants from acute rejection via the PD-L1/IL-17A axis.
    Ishibashi N; Watanabe T; Kanehira M; Watanabe Y; Hoshikawa Y; Notsuda H; Noda M; Sakurada A; Ohkouchi S; Kondo T; Okada Y
    Surg Today; 2018 Jul; 48(7):726-734. PubMed ID: 29546496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation.
    Yang M; Xu Z; Yan H; Tsai HI; Su D; Yan F; Lu Q; Feng J; Zeng W; Xi L; Zha H; Ling Y; He C; Wu Y; Xu X; Zheng G; Liu G; Chen H; Cheng F
    Biomater Sci; 2021 Feb; 9(4):1246-1255. PubMed ID: 33367372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes.
    Xu K; Ma D; Zhang G; Gao J; Su Y; Liu S; Liu Y; Han J; Tian M; Wei C; Zhang L
    Mol Immunol; 2021 Jul; 135():36-44. PubMed ID: 33857817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precise selection of aptamers targeting PD-L1 positive small extracellular vesicles on magnetic chips.
    Dong HY; Xie QH; Pang DW; Chen G; Zhang ZL
    Chem Commun (Camb); 2021 Apr; 57(29):3555-3558. PubMed ID: 33704314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Extracellular Vesicles Harboring PD-L1 in Obstructive Sleep Apnea.
    Recoquillon S; Ali S; Justeau G; Riou J; Martinez MC; Andriantsitohaina R; Gagnadoux F; Trzepizur W
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-derived small extracellular vesicles remodel the systemic onco-immunity via disrupting hematopoietic stem cell proliferation and differentiation.
    Du Z; Feng Y; Zhang H; Liu J; Wang J
    Cancer Lett; 2022 Oct; 545():215841. PubMed ID: 35921973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed death-1 targeting can promote allograft survival.
    Ozkaynak E; Wang L; Goodearl A; McDonald K; Qin S; O'Keefe T; Duong T; Smith T; Gutierrez-Ramos JC; Rottman JB; Coyle AJ; Hancock WW
    J Immunol; 2002 Dec; 169(11):6546-53. PubMed ID: 12444166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.